Anticoagulant properties of drotrecogin alfa (activated) during hemofiltration in patients with severe sepsis

In a retrospective study among 35 severely septic patients treated with drotrecogin alfa (activated) (DrotAA) and renal replacement therapy (RRT), Camporota and colleagues demonstrated that the addition of heparin, epoprostenol, or both to DrotAA during RRT did not improve filter survival. Furthermo...

Descripción completa

Detalles Bibliográficos
Autores principales: de Pont, Anne CJM, Schultz, Marcus J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688108/
https://www.ncbi.nlm.nih.gov/pubmed/19226446
http://dx.doi.org/10.1186/cc7684

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2688108/
https://www.ncbi.nlm.nih.gov/pubmed/19226446
http://dx.doi.org/10.1186/cc7684

Ejemplares similares